IL-2 Immunotherapy Curbs Locally Advanced Prostate Cancer May 2001

• "Universal" cancer vaccine shows promise in lab: Geron Corp, Duke University August 2000

• Vaccine using Telomerase tests on prostate cancer, other cancers, in San Diego and Paris April, 2000

• STEAP, new target antigen for prostate cancer diagnostics and therapies

• Vaccine Against Prostate Cancer Activates Entire Immune System, Johns Hopkins Team Says October, 1999

Gambling for a Prostate Cancer Cure: NBC Dateline Sept , 2000. "Three men take shot at a new chance at life with untested vaccine" Report on MSKCC Prostate Vaccine Phase I Results

For MSK vaccine trial report see JournalWatch link Slovin S, Carbohydrate vaccines "Five patients continue to have stable PSA slope profiles in the absence of any radiographic evidence of disease for more than 2 years."

• MSKCC Starts Trial of New Vaccine for Prostate Cancer Patients November 1998

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer Phase II Study

PSA-Based Vaccine and/or Radiotherapy to Treat Localized Prostate Cancer Phase II Study

PSA Vaccine or Nilutamide to Treat Advanced Prostate Cancer Phase II

• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy rPSA (recombinant PSA) prostate cancer vaccine Phase I trial, NCI sponsored. Check NCI Clinical Trials form for updates.